Survey Checking Whether Adults With Alzheimer Disease May Join Research
A survey asks adults with Alzheimer disease about eligibility for neurology studies.
Plain-language title generated from the registry record
Registry title: Triage Survey for Neurology Research Eligibility
Key facts
- Where
- Boston, New York, and Watertown, United StatesSee the 3 sites
Where in United States
- Copley ClinicalBoston, United StatesNot yet recruiting
- Berman ClinicalNew York, United StatesTaking people
- Adams ClinicalWatertown, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Adams Clinical
- Trial code
- NCT06104852
- Record updated
- 27 October 2026
- Original description
TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.Read full original descriptionShow less
Triage Survey for Neurology Research Eligibility
TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.
Inclusion: Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed; Participant and study partner (when applicable) are at least 18 years old.
Exclusion: Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant; History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results; Any condition that in the investigator's opinion makes a participant unsuitable for the study; Participant lacks the language skills or cognitive ability to understand the screening process; Participant is pregnant, breast-feeding, or planning to become pregnant; Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening; Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.